Today’s funding environment for small biotechs is tough. Valuations are down and money is tighter than it used to be – both for publicly listed and privately held firms.  

In these circumstances, obtaining the right backing – both in terms of finance and managerial advice – is more important than ever. 

In the fifth Optimum Perspectives podcast experienced investor Søren Møller talks to Optimum’s Stephen Adams about Novo Holdings Seed Investments’ approach to working with biotechs and what early-stage companies should look for in a financing partner. 

Hosted on Acast. See acast.com/privacy for more information.